These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34263940)

  • 1. Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI).
    Cooper N; Cuker A; Bonner N; Ghanima W; Provan D; Morgan M; Taylor B; D'Alessio D; Arnold D; Viana R
    Br J Haematol; 2021 Aug; 194(4):759-766. PubMed ID: 34263940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia.
    Viana R; D'Alessio D; Grant L; Cooper N; Arnold D; Morgan M; Provan D; Cuker A; Hill QA; Tomiyama Y; Ghanima W
    Adv Ther; 2021 Dec; 38(12):5791-5808. PubMed ID: 34704193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI).
    Tomiyama Y; Cheze S; Grant L; Bonner N; Affinito S; Nagano M; Rajput T; Viana R
    Int J Hematol; 2022 Oct; 116(4):500-527. PubMed ID: 35675024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in children and adolescents with immune thrombocytopenia.
    Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
    Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh).
    Chakrabarti P; George B; Shanmukhaiah C; Sharma LM; Udupi S; Ghanima W
    J Patient Rep Outcomes; 2022 Mar; 6(1):24. PubMed ID: 35303181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in adult primary immune thrombocytopenia.
    Sestøl HG; Trangbæk SM; Bussel JB; Frederiksen H
    Expert Rev Hematol; 2018 Dec; 11(12):975-985. PubMed ID: 30444433
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
    Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
    J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in adult patients with primary immune thrombocytopenia.
    Newton JL; Reese JA; Watson SI; Vesely SK; Bolton-Maggs PH; George JN; Terrell DR
    Eur J Haematol; 2011 May; 86(5):420-9. PubMed ID: 21323737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.
    Rüfer A; Terrell DR
    Br J Haematol; 2023 Oct; 203(1):79-85. PubMed ID: 37735553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
    Cooper N; Kruse A; Kruse C; Watson S; Morgan M; Provan D; Ghanima W; Arnold DM; Tomiyama Y; Santoro C; Michel M; Laborde S; Lovrencic B; Hou M; Bailey T; Taylor-Stokes G; Haenig J; Bussel JB
    Am J Hematol; 2021 Feb; 96(2):199-207. PubMed ID: 33107998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China.
    Zhang W; Xie S; Fu R; Chen Y; Liu W; Sun T; Ju M; Li H; Xue F; Zhang L; Liu X; Yang R
    Expert Rev Hematol; 2023; 16(12):1125-1133. PubMed ID: 38009277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.
    Flores A; Klaassen RJ; Buchanan GR; Neunert CE
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue perception in a cohort of children with chronic immune thrombocytopenia and their caregivers using the PedsQL MFS: Real-life multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Lassandro G; Palmieri VV; Barone A; Farruggia P; Giona F; Licciardello M; Marinoni M; Marzollo A; Notarangelo LD; Palumbo G; Ramenghi U; Russo G; Saracco P; Spinelli M; Tolva A; Tornesello A; Palladino V; Noviello D; Giordano P
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28840. PubMed ID: 33274837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.
    Buchbinder D; Nugent D; Hsieh L
    Drug Des Devel Ther; 2017; 11():1055-1063. PubMed ID: 28408804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study.
    Khelif A; Saleh MN; Salama A; Portella MDSO; Duh MS; Ivanova J; Grotzinger K; Roy AN; Bussel JB
    Am J Hematol; 2019 Feb; 94(2):200-208. PubMed ID: 30417939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in children with chronic immune thrombocytopenia in China.
    Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
    Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of ITP-BAT bleeding grading system for patients with immune thrombocytopenia].
    Lyu M; Liu X; Fu R; Sun T; Liu W; Lyu C; Yang R
    Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):812-5. PubMed ID: 25246249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
    Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
    J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lightening the load for paediatric ITP: The importance of health-related quality of life.
    Neunert CE; Lambert MP
    Br J Haematol; 2024 Oct; 205(4):1265-1266. PubMed ID: 39191677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.